BioWorld28 天
VRTX-531 demonstrates best-in-class USP1 inhibitor activity in preclinical models
Researchers from Vrise Therapeutics Inc. and Vegen Therapeutics Pvt Ltd. presented preclinical data for VRTX-531, an allosteric inhibitor of ubiquitin carboxyl-terminal hydrolase 1 (USP1), being ...